Title : Mesothelin is a novel cell surface disease marker and potential therapeutic target in acute myeloid leukemia.

Pub. Date : 2021 May 11

PMID : 33938941






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In vitro and in vivo preclinical efficacy of the MSLN-directed antibody-drug conjugates (ADCs) anetumab ravtansine and anti-MSLN-DGN462 were evaluated in MSLN+ leukemia cell lines in vitro and in vivo, as well as in patient-derived xenografts. Maytansine mesothelin Homo sapiens